GPT and liver disorder: Our FIB-4 score research has a disadvantage in that it is uncertain as to how it might predict outcomes in people with a history of hepatic disease, who can have drastic elevations of AST, ALT, and low platelet count, because we omitted these patients with pre-existing liver disease from our analysis.